Lymphoid Leukaemia

Lymphoid leukaemia is a type of blood cancer that affects the white blood cells, which are an important part of the body’s immune system. It is characterized by the uncontrolled production of abnormal white blood cells in the bone marrow. These abnormal cells can interfere with the normal function of the immune system and can spread to other parts of the body, such as the lymph nodes and spleen.

Lymphoid leukaemia is classified as either acute lymphoblastic leukaemia (ALL) or chronic lymphocytic leukaemia (CLL). ALL is more common in children and tends to progress rapidly, while CLL is more common in older adults and tends to progress more slowly.

Treatment for lymphoid leukaemia typically involves chemotherapy and, in some cases, radiation therapy, stem cell transplantation, or immunotherapy. The specific treatment plan will depend on the type and stage of the disease, as well as the patient’s overall health. Close monitoring and management by a team of healthcare professionals is important for individuals with lymphoid leukaemia to help prevent and manage complications and improve outcomes.